It’s not just obesity. Drugs like Ozempic will change the world
As they become cheaper, they promise to improve billions of lives
Every day seems to bring more exciting news. First the drugs tackled diabetes. Then, with just an injection a week, they took on obesity. Now they are being found to treat cardiovascular and kidney disease, and are being tested for Alzheimer’s and addiction. It is early days yet, but glp-1 receptor agonists have all the makings of one of the most successful classes of drugs in history. As they become cheaper and easier to use, they promise to dramatically improve the lives of more than a billion people—with profound consequences for industry, the economy and society.
This article appeared in the Leaders section of the print edition under the headline “The everything drugs ”
From the October 26th 2024 edition
Discover stories from this section and more in the list of contents
Explore the editionDiscover more
Peace in Lebanon is just a start
Donald Trump must build on Joe Biden’s belated success
From Nixon to China, to Trump to Tehran
Iran is weak. For America’s next president that creates an opportunity
Too many master’s courses are expensive and flaky
Governments should help postgraduates get a better deal
Elon Musk is Donald Trump’s disrupter-in-chief
The entrepreneur will be let loose on America’s government
Why British MPs should vote for assisted dying
A long-awaited liberal reform is in jeopardy
Germany cannot afford to wait to relax its debt brake
It should move before the election